Publications
Filters: First Letter Of Last Name is W [Clear All Filters]
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer." Breast Cancer Res Treat 166, no. 1 (2017): 167-177.
"Targeted cancer clinical trials." In Designs for Clinical Trials, 157-177. New York: Springer, 2012.
"Targeted Local Support Vector Machine for Age-Dependent Classification." J Am Stat Assoc 109, no. 507 (2014): 1174-1187.
"TEAM: efficient two-locus epistasis tests in human genome-wide association study." Bioinformatics 26, no. 12 (2010): i217-27.
" Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion." J Vet Intern Med 33, no. 2 (2019): 726-734.
"Time-dependent classification accuracy curve under marker-dependent sampling." Biom J 58, no. 4 (2016): 974-92.
"Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer." J Thorac Oncol 14, no. 2 (2019): 298-303.
"Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases." J Clin Oncol 34, no. 9 (2016): 945-52.
"Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases." J Clin Oncol 34, no. 9 (2016): 945-52.
"Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases." J Clin Oncol 34, no. 9 (2016): 945-52.
"Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial." Lancet Oncol 18, no. 6 (2017): 732-742.
"TwinMARM: two-stage multiscale adaptive regression methods for twin neuroimaging data." IEEE Trans Med Imaging 31, no. 5 (2012): 1100-12.
"Two-Dimensional Solution Surface for Weighted Support Vector Machines." J Comput Graph Stat 23, no. 2 (2014): 383-402.
"Unified Analysis of Secondary Traits in Case-Control Association Studies." J Am Stat Assoc 108, no. 502 (2013).
"Utility-based Weighted Multicategory Robust Support Vector Machines." Stat Interface 3, no. 4 (2010): 465-476.
"Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 22, no. 2 (2017): 189-198.
"Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials." Oncologist 22, no. 2 (2017): 189-198.
"Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups." Lung Cancer 90, no. 2 (2015): 281-7.
"Variable Selection for Support Vector Machines in Moderately High Dimensions." J R Stat Soc Series B Stat Methodol 78, no. 1 (2016): 53-76.
"Variable Selection for Support Vector Machines in Moderately High Dimensions." J R Stat Soc Series B Stat Methodol 78, no. 1 (2016): 53-76.
"Variable Selection in Kernel Regression Using Measurement Error Selection Likelihoods." J Am Stat Assoc 112, no. 520 (2017): 1587-1597.
"Variable Selection in Kernel Regression Using Measurement Error Selection Likelihoods." J Am Stat Assoc 112, no. 520 (2017): 1587-1597.
"Variable Selection in Nonparametric Classification via Measurement Error Model Selection Likelihoods." J Am Stat Assoc 109, no. 506 (2014): 574-589.
"Variable Selection in Nonparametric Classification via Measurement Error Model Selection Likelihoods." J Am Stat Assoc 109, no. 506 (2014): 574-589.
"Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma." Cancer Discov 7, no. 10 (2017): 1116-1135.
"